A detailed history of Motiv8 Investments LLC transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Motiv8 Investments LLC holds 1,620 shares of VRTX stock, worth $769,629. This represents 0.51% of its overall portfolio holdings.

Number of Shares
1,620
Previous 1,617 0.19%
Holding current value
$769,629
Previous $758 Million 0.59%
% of portfolio
0.51%
Previous 0.56%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 24, 2024

BUY
$460.0 - $505.78 $1,380 - $1,517
3 Added 0.19%
1,620 $753 Million
Q2 2024

Aug 06, 2024

BUY
$392.81 - $485.53 $81,311 - $100,504
207 Added 14.68%
1,617 $758 Million
Q1 2024

May 30, 2024

BUY
$407.69 - $446.08 $114,153 - $124,902
280 Added 24.78%
1,410 $589 Million
Q4 2023

May 30, 2024

BUY
$343.0 - $410.68 $387,590 - $464,068
1,130 New
1,130 $460 Million

Others Institutions Holding VRTX

About VERTEX PHARMACEUTICALS INC


  • Ticker VRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 256,691,008
  • Market Cap $122B
  • Description
  • Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...
More about VRTX
Track This Portfolio

Track Motiv8 Investments LLC Portfolio

Follow Motiv8 Investments LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Motiv8 Investments LLC, based on Form 13F filings with the SEC.

News

Stay updated on Motiv8 Investments LLC with notifications on news.